Ad
related to: sellas life sciences stock forecast this week- Planning for Retirement?
Boost to Your Retirement Plan
The 5 Best Stocks for Retirees
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- Planning for Retirement?
Search results
Results From The WOW.Com Content Network
SELLAS Life Sciences Group ( NASDAQ:SLS ) Third Quarter 2022 Results Key Financial Results Net loss: US$7.02m (flat on... SELLAS Life Sciences Group Third Quarter 2022 Earnings: US$0.34 loss per ...
Merger with Sellas Life Sciences. In 2017, Galena Biopharma Inc. announced a merger "with privately-held oncology company Sellas Life Sciences Group Ltd. in an all-stock transaction." The combined company was Sellas Life Science Group. The newly merged companies focused on the development of novel treatments for cancer.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...
For premium support please call: 800-290-4726 more ways to reach us
Liminal BioSciences' aim to develop best or first-in-class therapies targeting indications with significant unmet needs, where a novel small molecule approach may be better suited using its drug discovery platform, specialized know-how and data-driven development plans. Liminal BioSciences is a development stage biopharmaceutical company ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. [4]
May 10, 2024 at 2:10 PM. NEW YORK (AP) — U.S. stocks are coasting toward the close of another winning week on Friday. The S&P 500 was 0.1% higher in afternoon trading and on track for a third ...
Shirley Marie Tilghman, OC FRS (/ ˈ t ɪ l m ə n /; née Caldwell; born 17 September 1946) is a Canadian scholar in molecular biology and an academic administrator.She is now a professor of molecular biology and public policy and president emerita of Princeton University.
Ad
related to: sellas life sciences stock forecast this week